By Scientia Professor Anthony D Kelleher

Journal articles

Abayasingam A; Balachandran H; Agapiou D; Hammoud M; Rodrigo C; Keoshkerian E; Li H; Brasher NA; Christ D; Rouet R; Burnet D; Grubor-Bauk B; Rawlinson W; Turville S; Aggarwal A; Stella AO; Fichter C; Brilot F; Mina M; Post JJ; Hudson B; Gilroy N; Dwyer D; Sasson SC; Tea F; Pilli D; Kelleher A; Tedla N; Lloyd AR; Martinello M; Bull RA; Burnett D, 2021, 'Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection', Cell Reports Medicine, 2, pp. 100228, http://dx.doi.org/10.1016/j.xcrm.2021.100228

Kelleher AD, 2021, 'Acute treatment with monoclonal antibodies: Their design and their use', Microbiology Australia, 42, pp. 39 - 43, http://dx.doi.org/10.1071/MA21011

Murray DD; Zaunders J; Milliken ST; Mee Ling Munier C; Ford C; Orla Morrissey C; Visweswaran M; Avery S; Sasadeusz J; Kwan J; Desai S; Law M; Koelsch KK; Lewin SR; Moore J; Kelleher AD; Polizzotto MN; Munier ML; Law M, 2021, 'Altered Immune Reconstitution in Allogeneic Stem Cell Transplant Recipients with Human Immunodeficiency Virus (HIV)', Clinical Infectious Diseases, 72, pp. 1141 - 1146, http://dx.doi.org/10.1093/cid/ciaa748

Darley D; Matthews G; Dore G; Wilhelm K; Plit M; Stone E; Byrne A; Tonga K; Andresen D; Kelleher A; Cysique L; Cunningham P; Brew B, 2021, 'Persistent symptoms up to four months after community and hospital- managed SARS- CoV- 2 infection', Medical Journal of Australia, http://dx.doi.org/10.5694/mja2.50963

Mar Minn M; Aung NM; Kyaw DZ; Zaw TT; Chann PN; Khine HE; McLoughlin S; Kelleher AD; Tun NL; Oo TZC; Myint NPST; Law M; Mar Kyi M; Hanson J, 2021, 'The comparative ability of commonly used disease severity scores to predict death or a requirement for ICU care in patients hospitalised with possible sepsis in Yangon, Myanmar', International Journal of Infectious Diseases, 104, pp. 543 - 550, http://dx.doi.org/10.1016/j.ijid.2021.01.047

Walker GJ; Naing Z; Stella AO; Yeang M; Caguicla J; Ramachandran V; Isaacs SR; Agapiou D; Bull RA; Stelzer-Braid S; Daly J; Gosbell IB; Hoad VC; Irving DO; Pink JM; Turville S; Kelleher AD; Rawlinson WD, 2021, 'Sars coronavirus-2 microneutralisation and commercial serological assays correlated closely for some but not all enzyme immunoassays', Viruses, 13, http://dx.doi.org/10.3390/v13020247

Seddiki N; Zaunders J; Phetsouphanh C; Brezar V; Xu Y; McGuire HM; Bailey M; McBride K; Hey-Cunningham W; Munier CML; Cook L; Kent S; Lloyd A; Cameron B; De St Groth BF; Koelsch K; Danta M; Hocini H; Levy Y; Kelleher AD, 2021, 'CD73+ CD127high long-term memory CD4 T cells are highly proliferative in response to recall antigens and are early targets in hiv-1 infection', International Journal of Molecular Sciences, 22, pp. 1 - 28, http://dx.doi.org/10.3390/ijms22020912

Ubolyam S; Iampornsin T; Sophonphan J; Avihingsanon A; Suwanpimolkul G; Kawkitinarong K; Manosuthi W; Gatechompol S; Ananworanich J; Ruxrungtham K; Phanuphak P; Kelleher AD, 2021, 'Performance of a simple flow cytometric assay in diagnosing active tuberculosis', Tuberculosis, 126, http://dx.doi.org/10.1016/j.tube.2020.102017

Rouet R; Mazigi O; Walker GJ; Langley DB; Sobti M; Schofield P; Lenthall H; Jackson J; Ubiparipovic S; Henry JY; Abayasingam A; Burnett D; Kelleher A; Brink R; Bull RA; Turville S; Stewart AG; Goodnow CC; Rawlinson WD; Christ D, 2021, 'Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies', Mabs, 13, http://dx.doi.org/10.1080/19420862.2021.1922134

Di Giallonardo F; Pinto AN; Keen P; Shaik A; Carrera A; Salem H; Selvey C; Nigro SJ; Fraser N; Price K; Holden J; Lee FJ; Dwyer DE; Bavinton BR; Geoghegan JL; Grulich AE; Kelleher AD; Guy R; Prestage G; Zablotska I; Holden J; Duck T; Cooper C; Holt M; de Wit J; Kaldor J; Wilson D; Brotherton A; Cooper DA; Crooks L; Whittaker B; Callander D; Madeddu D; Schmidt HM; Telfer B; Boyd M; McGill S; Patel P; Power C; Gordon T; Feeney L; Bath K; Mackie B, 2021, 'Subtype-specific differences in transmission cluster dynamics of HIV-1 B and CRF01_AE in New South Wales, Australia', Journal of the International AIDS Society, 24, pp. e25655, http://dx.doi.org/10.1002/jia2.25655

Phetsouphanh C; Darley D; Wilson D; Howe A; Ling Munier M; Patel S; Juno J; Burrell L; Kent S; Dore G; Kelleher A; Matthews G, 2021, 'Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection', , http://dx.doi.org/10.1101/2021.06.01.21257759

Darley DR; Dore GJ; Byrne A; Plit M; Brew BJ; Kelleher A; Matthews GV, 2021, 'Limited recovery from post-acute sequelae of SARS-CoV-2 (PASC) at eight months in a prospective cohort', , http://dx.doi.org/10.1101/2021.03.29.21254211

Tea F; Stella AO; Aggarwal A; Darley DR; Pilli D; Vitale D; Merheb V; Lee FXZ; Cunningham P; Walker GJ; Brown DA; Rawlinson WD; Isaacs SR; Mathivanan V; Hoffman M; Pöhlmann S; Dwyer DE; Rockett R; Sintchenko V; Hoad VC; Irving DO; Dore GJ; Gosbell IB; Kelleher AD; Matthews GV; Brilot F; Turville SG, 2020, 'SARS-CoV-2 neutralizing antibodies; longevity, breadth, and evasion by emerging viral variants', , http://dx.doi.org/10.1101/2020.12.19.20248567

Di Giallonardo F; Pinto AN; Keen P; Shaik A; Carrera A; Salem H; Selvey C; Nigro SJ; Fraser N; Price K; Holden J; Lee FJ; Dwyer DE; Bavinton BR; Grulich AE; Kelleher AD, 2020, 'Increased hiv subtype diversity reflecting demographic changes in the hiv epidemic in new south wales, australia', Viruses, 12, pp. 1402, http://dx.doi.org/10.3390/v12121402

Li Z; Khanna M; Grimley SL; Ellenberg P; Gonelli CA; Lee WS; Amarasena TH; Kelleher AD; Purcell DFJ; Kent SJ; Ranasinghe C, 2020, 'Mucosal IL-4R antagonist HIV vaccination with SOSIP-gp140 booster can induce high-quality cytotoxic CD4+/CD8+ T cells and humoral responses in macaques', Scientific Reports, 10, http://dx.doi.org/10.1038/s41598-020-79172-7

Sasson SC; Zaunders JJ; Nahar K; Munier CML; Fairfax BP; Olsson-Brown A; Jolly C; Read SA; Ahlenstiel G; Palendira U; Scolyer RA; Carlino MS; Payne MJ; Cheung VTF; Gupta T; Klenerman P; Long GV; Brain O; Menzies AM; Kelleher AD, 2020, 'Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitis', Clinical and Experimental Immunology, 202, pp. 335 - 352, http://dx.doi.org/10.1111/cei.13502

Law H; Venturi V; Kelleher A; Mee Ling Munier C, 2020, 'Tfh cells in health and immunity: Potential targets for systems biology approaches to vaccination', International Journal of Molecular Sciences, 21, pp. 1 - 21, http://dx.doi.org/10.3390/ijms21228524

Van Bockel D; Munier CML; Turville S; Badman SG; Walker G; Stella AO; Aggarwal A; Yeang M; Condylios A; Kelleher AD; Applegate TL; Vallely A; Whiley D; Rawlinson W; Cunningham P; Kaldor J; Guy R, 2020, 'Evaluation of commercially available viral transport medium (VTM) for SARS-CoV-2 inactivation and use in point-of-care (POC) testing', Viruses, 12, pp. 1208, http://dx.doi.org/10.3390/v12111208

Kelleher AD; Cortez-Jugo C; Cavalieri F; Qu Y; Glanville AR; Caruso F; Symonds G; Ahlenstiel CL, 2020, 'RNAi therapeutics: an antiviral strategy for human infections', Current Opinion in Pharmacology, 54, pp. 121 - 129, http://dx.doi.org/10.1016/j.coph.2020.09.011

Mwasakifwa GE; Amin J; White CP; Center JR; Kelleher A; Boyd MA, 2020, 'Early changes in bone turnover and inflammatory biomarkers and clinically significant bone mineral density loss over 48 weeks among HIV-infected patients with virological failure of a standard first-line antiretroviral therapy regimen in the SECOND-LINE study', HIV Medicine, 21, pp. 492 - 504, http://dx.doi.org/10.1111/hiv.12882

Ahlenstiel CL; Symonds G; Kent SJ; Kelleher AD, 2020, 'Block and Lock HIV Cure Strategies to Control the Latent Reservoir', Frontiers in Cellular and Infection Microbiology, 10, http://dx.doi.org/10.3389/fcimb.2020.00424

Wragg KM; Tan HX; Kristensen AB; Nguyen-Robertson CV; Kelleher AD; Parsons MS; Wheatley AK; Berzins SP; Pellicci DG; Kent SJ; Juno JA, 2020, 'High CD26 and Low CD94 Expression Identifies an IL-23 Responsive Vδ2+ T Cell Subset with a MAIT Cell-like Transcriptional Profile', Cell Reports, 31, http://dx.doi.org/10.1016/j.celrep.2020.107773

Zaunders J; Mee Ling Munier C; McGuire HM; Law H; Howe A; Xu Y; De St Groth BF; Schofield P; Christ D; Milner B; Obeid S; Dyer WB; Saksena NK; Kelleher AD; Munier ML, 2020, 'Mapping the extent of heterogeneity of human CCR5R CD4R T cells in peripheral blood and lymph nodes', AIDS, 34, pp. 833 - 848, http://dx.doi.org/10.1097/QAD.0000000000002503

Kelleher A; Breit S; Levy JA, 2020, 'Professor Ronald Penny IN MEMORIAM', AIDS, 34, pp. 959 - 960, http://dx.doi.org/10.1097/QAD.0000000000002520

Singh M; Jackson KJL; Wang JJ; Schofield P; Field MA; Koppstein D; Peters TJ; Burnett DL; Rizzetto S; Nevoltris D; Masle-Farquhar E; Faulks ML; Russell A; Gokal D; Hanioka A; Horikawa K; Colella AD; Chataway TK; Blackburn J; Mercer TR; Langley DB; Goodall DM; Jefferis R; Gangadharan Komala M; Kelleher AD; Suan D; Rischmueller M; Christ D; Brink R; Luciani F; Gordon TP; Goodnow CC; Reed JH, 2020, 'Lymphoma Driver Mutations in the Pathogenic Evolution of an Iconic Human Autoantibody', Cell, 180, pp. 878 - 894.e19, http://dx.doi.org/10.1016/j.cell.2020.01.029

Cook L; Munier CML; Seddiki N; Hardy MY; Anderson RP; Zaunders J; Tye-Din JA; Kelleher AD; van Bockel D, 2020, 'Circulating gluten-specific, but not CMV-specific, CD39+ regulatory T cells have an oligoclonal TCR repertoire', Clinical and Translational Immunology, 9, pp. e1096, http://dx.doi.org/10.1002/cti2.1096

Pilli D; Zou A; Dawes R; Lopez JA; Tea F; Liyanage G; Lee FXZ; Merheb V; Houston SD; Pillay A; Jones HF; Ramanathan S; Mohammad S; Kelleher AD; Alexander SI; Dale RC; Brilot F, 2020, 'Pro-inflammatory dopamine-2 receptor-specific T cells in paediatric movement and psychiatric disorders', Clinical and Translational Immunology, 9, http://dx.doi.org/10.1002/cti2.1229

Breit S; Ziegler J; Kelleher AD, 2020, 'Vale Ron Penny AO (1936-2019): pioneer of clinical immunology OBITUARY', CLINICAL & TRANSLATIONAL IMMUNOLOGY, 9, http://dx.doi.org/10.1002/cti2.1119

Rouet R; Mazigi O; Walker G; Langley D; Sobti M; Schofield P; Lenthall H; Jackson J; Ubiparipovic S; Henry J; Abayasingam A; Burnett D; Kelleher A; Brink R; Bull R; Turville S; Stewart A; Goodnow C; Rawlinson W; Christ D, 2020, 'Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies', , http://dx.doi.org/10.1101/2020.12.14.422791

Walker G; Naing Z; Stella AO; Yeang M; Caguicla J; Ramachandran V; Isaacs S; Agapiou D; Bull R; Stelzer-Braid S; Daly J; Gosbell I; Hoad V; Irving D; Pink J; Turville S; Kelleher A; Rawlinson W, 2020, 'SARS Coronavirus-2 microneutralisation and commercial serological assays correlated closely for some but not all enzyme immunoassays', , http://dx.doi.org/10.1101/2020.12.07.20245696

Selva KJ; Bavinton BR; Grulich AE; Pazgier M; Kelleher AD; Kent SJ; Parsons MS, 2019, 'Impact of HIV-1 viremia or sexually transmitted infection on semen-derived anti-HIV-1 antibodies and the immunosuppressive capacity of seminal plasma', European Journal of Immunology, 49, pp. 2255 - 2258, http://dx.doi.org/10.1002/eji.201848055

Khanna M; Jackson RJ; Alcantara S; Amarasena TH; Li Z; Kelleher AD; Kent SJ; Ranasinghe C, 2019, 'Mucosal and systemic SIV-specific cytotoxic CD4 + T cell hierarchy in protection following intranasal/intramuscular recombinant pox-viral vaccination of pigtail macaques', Scientific Reports, 9, http://dx.doi.org/10.1038/s41598-019-41506-5

Vaccher SJ; Marzinke MA; Templeton DJ; Haire BG; Ryder N; McNulty A; Foster R; Grulich AE; Zablotska IB; Bloch M; Carr A; Cheung C; Gianacas C; Guy R; Holt M; Kaldor J; Mackie B; Mayer K; McAllister J; Murphy D; Ooi C; Pell C; Poynten IM; Prestage G; de Wit J; Wright E; Callander D; Cooper D; Crooks L; Duck T; Holden J; Keen P; Kelleher A; Mitchell J; Price K; Selvey C; Schmidt HM; Telfer B; Whittaker B; Wilson D; Cooper D, 2019, 'Predictors of Daily Adherence to HIV Pre-exposure Prophylaxis in Gay/Bisexual Men in the PRELUDE Demonstration Project', AIDS and Behavior, 23, pp. 1287 - 1296, http://dx.doi.org/10.1007/s10461-018-2353-5

Di Giallonardo F; Pinto AN; Keen P; Shaik A; Carrera A; Salem H; Telfer B; Cooper C; Price K; Selvey C; Holden J; Bachmann N; Lee FJ; Dwyer DE; Duchêne S; Holmes EC; Grulich AE; Kelleher AD; Kelleher A; Prestage G; de Wit J; Guy R, 2019, 'Limited sustained local transmission of HIV-1 CRF01_AE in New South Wales, Australia', Viruses, 11, pp. 482, http://dx.doi.org/10.3390/v11050482

Zaunders J; Dyer WB; Churchill M; Munier CML; Cunningham PH; Suzuki K; McBride K; Hey-Nguyen W; Koelsch K; Wang B; Hiener B; Palmer S; Gorry PR; Bailey M; Xu Y; Danta M; Seddiki N; Cooper DA; Saksena NK; Sullivan JS; Riminton S; Learmont J; Kelleher AD, 2019, 'Possible clearance of transfusion-acquired nef/LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Delta 32 heterozygous and HLA-B57 genotype', JOURNAL OF VIRUS ERADICATION, 5, pp. 73 - 83, http://dx.doi.org/10.1016/s2055-6640(20)30056-x

Bavinton BR; Prestage GP; Jin F; Phanuphak N; Grinsztejn B; Fairley CK; Baker D; Hoy J; Templeton DJ; Tee BK; Kelleher A; Grulich AE; Zablotska-Manos I; Cooper D; Triffitt K; Bloch M; McNulty A; Pell C; Emery S, 2019, 'Strategies used by gay male HIV serodiscordant couples to reduce the risk of HIV transmission from anal intercourse in three countries', Journal of the International AIDS Society, 22, pp. e25277, http://dx.doi.org/10.1002/jia2.25277

Van Santen DK; Van Der Helm JJ; Touloumi G; Pantazis N; Muga R; Gunsenheimer-Bartmeyer B; Gill MJ; Sanders E; Kelleher A; Zangerle R; Porter K; Prins M; Geskus RB, 2019, 'Effect of incident hepatitis C infection on CD4 cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort', AIDS, 33, pp. 327 - 337, http://dx.doi.org/10.1097/QAD.0000000000002040

Hemelaar J; Elangovan R; Yun J; Dickson-Tetteh L; Fleminger I; Kirtley S; Williams B; Gouws-Williams E; Ghys PD; Abimiku AG; Agwale S; Archibald C; Avidor B; Barbás MG; Barre-Sinoussi F; Barugahare B; Belabbes EH; Bertagnolio S; Birx D; Bobkov AF; Brandful J; Bredell H; Brennan CA; Brooks J; Bruckova M; Buonaguro L; Buonaguro F; Buttò S; Buve A; Campbell M; Carr J; Carrera A; Carrillo MG; Celum C; Chaplin B; Charles M; Chatzidimitriou D; Chen Z; Chijiwa K; Cooper D; Cunningham P; Dagnra A; de Gascun CF; Del Amo J; Delgado E; Dietrich U; Dwyer D; Ellenberger D; Ensoli B; Essex M; Gao F; Fleury H; Fonjungo PN; Foulongne V; Gadkari DA; García F; Garsia R; Gershy-Damet GM; Glynn JR; Goodall R; Grossman Z; Lindenmeyer-Guimarães M; Hahn B; Hamers RL; Hamouda O; Handema R; He X; Herbeck J; Ho DD; Holguin A; Hosseinipour M; Hunt G; Ito M; Bel Hadj Kacem MA; Kahle E; Kaleebu PK; Kalish M; Kamarulzaman A; Kang C; Kanki P; Karamov E; Karasi JC; Kayitenkore K; Kelleher T; Kitayaporn D; Kostrikis LG; Kucherer C; Lara C; Leitner T; Liitsola K; Lingappa J; Linka M; Lorenzana de Rivera I; Lukashov V; Maayan S; Mayr L; McCutchan F; Meda N; Menu E; Mhalu F, 2019, 'Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis', Lancet Infectious Diseases, 19, pp. 143 - 155, http://dx.doi.org/10.1016/S1473-3099(18)30647-9

Gossez M; Martin GE; Pace M; Ramjee G; Premraj A; Kaleebu P; Rees H; Inshaw J; Stöhr W; Meyerowitz J; Hopkins E; Jones M; Hurst J; Porter K; Babiker A; Fidler S; Frater J, 2019, 'Virological remission after antiretroviral therapy interruption in female African HIV seroconverters', AIDS, 33, pp. 185 - 197, http://dx.doi.org/10.1097/QAD.0000000000002044

Cahn P; Madero JS; Arribas JR; Antinori A; Ortiz R; Clarke AE; Hung CC; Rockstroh JK; Girard PM; Sievers J; Man C; Currie A; Underwood M; Tenorio AR; Pappa K; Wynne B; Fettiplace A; Gartland M; Aboud M; Smith K; Cassetti L; David D; Figueras L; Losso M; Lopardo G; Lupo S; Porteiro N; Sánchez M; Bloch M; Cooper D; Finlayson R; Kelleher A; Koh K; Lewis D; McMahon J; Moore R; Roth N; Shields M; De Wit S; Florence E; Goffard JC; Demeester R; Lacor P; Vandercam B; Vandekerckhove L; Angel J; Baril JG; Conway B; De Pokomandy A; Szabo J; Walmsley S; Bouchaud O; Chidiac C; Delobel P; Goujard C; Katlama C; Molina JM; Pialoux G; Philibert P; Bogner J; Esser S; Krznaric I; Lehmann C; Spinner C; Stellbrink HJ; Stephan C; Stoehr A; Barchi E; Caramello P; Castelli F; Cattelan AM; D'Arminio Monforte A; Di Biagio A; Di Perri G; Gori A; Maggiolo F; Menzaghi B; Migliorino G; Mussini C; Penco G; Puoti M; Rizzardini G; Gulminetti R; Lazzarin A; Quirino T; Sighinolfi L; Viale P; Amaya Tapia G; Andrade Villanueva J; Granados Reyes ER; Perez Rios A; Santoscoy Gomez M; Den Hollander J; Rijnders B; Hidalgo JA; Hercilla Vasquez L; Illescas L; Olczak A; Mansinho K; Correia Pacheco PP, 2019, 'Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials', Lancet, 393, pp. 143 - 155, http://dx.doi.org/10.1016/S0140-6736(18)32462-0

Davenport MP; Khoury DS; Cromer D; Lewin SR; Kelleher AD; Kent SJ, 2019, 'Functional cure of HIV: the scale of the challenge', Nature Reviews Immunology, 19, pp. 45 - 54, http://dx.doi.org/10.1038/s41577-018-0085-4

Hey-Nguyen WJ; Bailey M; Xu Y; Suzuki K; Van Bockel D; Finlayson R; Leigh Brown A; Carr A; Cooper DA; Kelleher AD; Koelsch KK; Zaunders JJ, 2019, 'HIV-1 DNA Is Maintained in Antigen-Specific CD4+ T Cell Subsets in Patients on Long-Term Antiretroviral Therapy Regardless of Recurrent Antigen Exposure', AIDS Research and Human Retroviruses, 35, pp. 112 - 120, http://dx.doi.org/10.1089/aid.2018.0235

Phetsouphanh C; Aldridge D; Marchi E; Munier CML; Meyerowitz J; Murray L; Van Vuuren C; Goedhals D; Fidler S; Kelleher A; Klenerman P; Frater J, 2019, 'Maintenance of functional CD57+ cytolytic CD4+ T cells in HIV+ elite controllers', Frontiers in Immunology, 10, http://dx.doi.org/10.3389/fimmu.2019.01844

Juno JA; Wragg KM; Kristensen AB; Lee WS; Selva KJ; Van Der Sluis RM; Kelleher AD; Bavinton BR; Grulich AE; Lewin SR; Kent SJ; Parsons MS, 2019, 'Modulation of the CCR5 Receptor/Ligand Axis by Seminal Plasma and the Utility of in Vitro versus in Vivo Models', Journal of Virology, 93, pp. 10.1128/jvi.00242 - 10.1128/jvi.00219, http://dx.doi.org/10.1128/JVI.00242-19

Sasson SC; Cheung VTF; Gupta T; Zaunders JJ; Nahar K; Munier CM-L; Olsson-Brown A; Ahlenstiel G; Palendira U; Scolyer RA; Carlino MS; Long GV; Menzies AM; Kelleher A; Payne M; Fairfax B; Middleton MR; Klenerman P; Brain O, 2019, '1303P Tissue-based activation of mucosal-associated invariant T (MAIT) cells in combination ipilimumab and nivolumab checkpoint inhibitor (CI) colitis', Annals of Oncology, 30, pp. v530, http://dx.doi.org/10.1093/annonc/mdz253.128

Polizzotto M; Van Bockel D; Law C; Roberts J; Buckland G; Just S; Comben S; Hillman R; Gilson R; Pett S; Poynten M; Law M; Kelleher A; Emery S, 2019, 'Clearance of HPV Anal Premalignant Lesions and Modulation of Systemic Immune Responses to HPV Oncogenes with Low Dose Pomalidomide', Annals of Oncology, 30, pp. xi35 - xi35, http://dx.doi.org/10.1093/annonc/mdz451.005

Moran I; Nguyen A; Khoo WH; Butt D; Bourne K; Young C; Hermes JR; Biro M; Gracie G; Ma CS; Munier CML; Luciani F; Zaunders J; Parker A; Kelleher AD; Tangye SG; Croucher PI; Brink R; Read MN; Phan TG, 2018, 'Memory B cells are reactivated in subcapsular proliferative foci of lymph nodes', Nature Communications, 9, pp. 3372, http://dx.doi.org/10.1038/s41467-018-05772-7

Pinto AN; Grey P; Shaik A; Cooper DA; Kelleher AD; Petoumenos K, 2018, 'Early Treatment of Primary HIV Infection Is Associated with Decreased Mortality', AIDS Research and Human Retroviruses, 34, pp. 936 - 941, http://dx.doi.org/10.1089/aid.2017.0284

Méndez C; Ledger S; Petoumenos K; Ahlenstiel C; Kelleher AD, 2018, 'RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency', Retrovirology, 15, pp. 67, http://dx.doi.org/10.1186/s12977-018-0451-0

Kent SJ; Hough S; Kelleher AD; Law MG; Hutchinson J; Catalfarmo M; van Bockel D; Lane C; Baker JV; Emery S; Han A, 2018, 'Vorapaxar for HIV-associated inflammation and coagulopathy (ADVICE): a randomised, double-blind, placebo-controlled trial', Lancet HIV, 5, pp. e553 - e559, http://dx.doi.org/10.1016/S2352-3018(18)30214-5

Back to profile page